PolyNovo Future Growth
Future criteria checks 5/6
PolyNovo is forecast to grow earnings and revenue by 38.4% and 17.5% per annum respectively. EPS is expected to grow by 37.8% per annum. Return on equity is forecast to be 28.1% in 3 years.
Key information
38.4%
Earnings growth rate
37.8%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 17.5% |
| Future return on equity | 28.1% |
| Analyst coverage | Good |
| Last updated | 25 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 207 | 37 | 30 | 35 | 8 |
| 6/30/2026 | 168 | 23 | 13 | 21 | 9 |
| 6/30/2025 | 134 | 9 | -9 | 6 | 9 |
| 6/30/2024 | 103 | 5 | 1 | 4 | N/A |
| 3/31/2024 | 93 | 3 | -3 | 0 | N/A |
| 12/31/2023 | 83 | 2 | -6 | -3 | N/A |
| 9/30/2023 | 75 | -2 | -7 | -5 | N/A |
| 6/30/2023 | 66 | -5 | -8 | -7 | N/A |
| 3/31/2023 | 59 | -6 | -5 | -4 | N/A |
| 12/31/2022 | 53 | -7 | -2 | -2 | N/A |
| 9/30/2022 | 48 | -4 | -2 | -2 | N/A |
| 6/30/2022 | 42 | -1 | -3 | -2 | N/A |
| 3/31/2022 | 38 | 0 | -3 | -2 | N/A |
| 12/31/2021 | 35 | 1 | -4 | -2 | N/A |
| 9/30/2021 | 32 | -2 | -4 | -1 | N/A |
| 6/30/2021 | 29 | -5 | -4 | 0 | N/A |
| 3/31/2021 | 27 | -5 | -6 | 0 | N/A |
| 12/31/2020 | 25 | -5 | -7 | 0 | N/A |
| 9/30/2020 | 24 | -5 | -8 | 0 | N/A |
| 6/30/2020 | 22 | -4 | -9 | 0 | N/A |
| 3/31/2020 | 20 | -4 | -11 | -2 | N/A |
| 12/31/2019 | 18 | -4 | -13 | -3 | N/A |
| 9/30/2019 | 16 | -3 | -11 | -3 | N/A |
| 6/30/2019 | 14 | -3 | -10 | -3 | N/A |
| 3/31/2019 | 12 | -4 | -8 | -5 | N/A |
| 12/31/2018 | 9 | -5 | -7 | -6 | N/A |
| 9/30/2018 | 8 | -5 | -7 | -7 | N/A |
| 6/30/2018 | 7 | -6 | -7 | -7 | N/A |
| 3/31/2018 | 6 | -6 | N/A | -7 | N/A |
| 12/31/2017 | 5 | -6 | N/A | -7 | N/A |
| 9/30/2017 | 4 | -6 | N/A | -6 | N/A |
| 6/30/2017 | 4 | -5 | N/A | -5 | N/A |
| 3/31/2017 | 4 | -4 | N/A | -4 | N/A |
| 12/31/2016 | 5 | -3 | N/A | -3 | N/A |
| 9/30/2016 | 4 | -3 | N/A | -3 | N/A |
| 6/30/2016 | 3 | -3 | N/A | -4 | N/A |
| 3/31/2016 | 2 | -3 | N/A | -4 | N/A |
| 12/31/2015 | 0 | -2 | N/A | -4 | N/A |
| 9/30/2015 | 0 | -2 | N/A | -3 | N/A |
| 6/30/2015 | 0 | -1 | N/A | -3 | N/A |
| 3/31/2015 | 0 | -2 | N/A | -2 | N/A |
| 12/31/2014 | 0 | -3 | N/A | -2 | N/A |
| 9/30/2014 | 0 | -3 | N/A | -2 | N/A |
| 6/30/2014 | 0 | -3 | N/A | -3 | N/A |
| 3/31/2014 | 0 | -2 | N/A | -3 | N/A |
| 12/31/2013 | 0 | -2 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CALZ.F's forecast earnings growth (38.4% per year) is above the savings rate (2.6%).
Earnings vs Market: CALZ.F's earnings (38.4% per year) are forecast to grow faster than the US market (15.4% per year).
High Growth Earnings: CALZ.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CALZ.F's revenue (17.5% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: CALZ.F's revenue (17.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CALZ.F's Return on Equity is forecast to be high in 3 years time (28.1%)